A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction (Q37697608)
Jump to navigation
Jump to search
scientific article published on 24 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction |
scientific article published on 24 February 2010 |
Statements
1 reference
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction (English)
1 reference
Juan W Valle
1 reference
Anne Armstrong
1 reference
Chris Newman
1 reference
Valery Alakhov
1 reference
Grzegorz Pietrzynski
1 reference
Julie Brewer
1 reference
Sue Campbell
1 reference
Pippa Corrie
1 reference
Eric K Rowinsky
1 reference
Malcolm Ranson
1 reference
24 February 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference